Immune privileged and modulatory progenitor cells
US8277794B2 · kind B2 · utility
1Cited by
3References
14Claims
0Family size
Inventors
Key dates
| Filing date | May 4, 2007 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Sep 23, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/0665
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein is a method for modulating an immune reaction between lymphocytes and a body recognized by the lymphocytes as foreign. The method exploits the immunomodulating activity of a new class of progenitor cells termed HUCPVCs derived from the perivascular region of human umbilical cord. The method can also employ soluble factors exuded by cultured HUCPVCs. The method is useful to treat immune disorders including graft versus host disease, autoimmune disorders, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.